Risk of suicide attempts after benzodiazepine and/or antidepressant use

Annals of Epidemiology

Volumn 7, Issue 8, 1997, Pages 568-574

  Neutel, C Ineke ^a   Patten, Scott B ^b  

^a HEALTH CANADA   (Canada)

^b Health Canada Al#41031 ^*  (Canada)

Author keywords

Antidepressants; Benzodiazepines; Confounding by Indication; Pharmacoepidemiology; Suicides

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; ARTICLE; DEPRESSION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHARMACOEPIDEMIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SUICIDE ATTEMPT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; RISK FACTORS; SEX FACTORS; SUICIDE, ATTEMPTED;

EID: 0030735138     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(97)00126-9     Document Type: Article

References (31)

1. Isacsson G, Holmgren P, Wasserman D, Bergman U. Use of antidepressants among people committing suicide in Sweden. BMJ. 1994;308:506-509.
2. Isacsson G, Boethius G, Bergman U. Low level of antidepressant prescription for people who alter commit suicide: 15 years of experience from a population-based drug database in Sweden. Acta Psychiatr Scand. 1992;85:444-448.
3. Isacsson G, Bergman U, Rich CL. Antidepressants, depression and suicide: an analysis of the San Diego study. J Affect Disord. 1994; 32:277-286.
4. Buckley NA, Dawson AH, Whyte IM, O'Connell DLO. Relative toxicity of benzodiazepines in overdose. BMJ. 1995;6974:219-221.
5. Henry JA. Toxicity of antidepressant: comparisons with fluoxetine. Int Clin Psychopharmacol. 1992;6(Suppl 6):22-27.
6. Mendelson WB, Rich CL. Sedatives and suicide: the San Diego study. Acta Psychiatr Scand. 1993;88:337-341.
7. Derby LE, Jick H, Dean AD. Antidepressant drugs and suicide. J Clin Psychopharmacol. 1992;12:235-240.
8. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ. 1995;310:215-218.
9. Kapur S, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempts and suicide. JAMA. 1992;268:3441-3445.
10. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ. 1995;310:221-224.
11. Nierenberg AA. The medical consequences of the selection of an antidepressant. J Clin Psychiatry. 1992;53(Suppl 9):19-24.
12. Malcolm E, Downey W, Strand L, McNutt M, West R. Saskatchewan Health's linkable data bases and pharmacoepidemiology. Post Marketing Surveill. 1993;6:175-264.
13. Neutel CI, Downey W, Senft D. Medical events after a prescription for a benzodiazepine. Pharmacoepidemiol Drug Safety. 1995;6:175-264.
14. World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death. Geneva; 1977.
15. SAS Institute Inc. SAS User Guide, Release 6.03 Edition. Cary, NC: SAS Institute Inc; 1997.
16. Goldblatt MJ, Schatzberg AF. Does treatment with antidepressants increase suicidal behaviour? Int Clin Psychopharmacol. 1991;6:219-226.
17. Moller HJ. Antidepressants-Do they decrease or increase suicidality? Pharmacopsychiat. 1992;25:249-253.
18. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Safety. 1993;8:186-212.
19. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Annals of Epidemiol. 1995;5:239-244.
20. Johnston KC, Helston DR, Sherman GJ. Anticonvulsant use and congenital malformation in Saskatchewan: Creation of a prescription drug use pregnancy outcome database. J Clin Res Drug Dev. 1989;3:215.
21. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA. 1989;262:3303-3307.
22. Ferez Gutthann S, Garcia Rodriquez LA, Raford DS. Individual non-steroidal anti-inflammatory drugs and other risk factors for upper gastrointestinal bleeding 22. and perforation. Epidemiology. 1997;8:18-24.
23. Rawson NSB, D'Arcy C, Blackburn JL et al. Epidemiologic research using linked computerized health care datafiles in Saskatchewan, Canada. Technical Report no. 2, Saskatoon, Saskatchewan: Psychiatric Pharmacoepidemiology Research Consortium, University of Saskatchewan; 1997.
24. Rawson NSB. Aspects of the validity of the Saskatchewan administrative health care utilization datafiles: An exploratory analysis. Presented at The Canadian Pharmacoepidemiology Forum, Toronto, April 1994.
25. Neutel CI, Hirdes JP, Maxwell CJ, Patten SB. New evidence on benzodiazepine use and falls - the time factor. Age and Ageing 1996;25:273-278.
26. Fawcett J. Antidepressants: partial response in chronic depression. Brit J Psychiatry. 1994;165(Suppl):37-41.
27. Isometsa ET, Heikkinen ME, Marttunen MJ, Henrikson MM, Aro HM, Lonnqvsit JK. The last appointment before suicide: is suicide intent communicated? Am J Psychiatry. 1995;152:919-922.
28. Corruble E, Puech AJ. How to improve the risk-benefit ratio of antidepressants. Int Clin Psychopharmacol. 1993;8:237-241.
29. Neutel CI, Walop W, Appel WC. Triazolam use and potential for violence: The need for epidemiologic research. Chronic Diseases in Canada 1991;12:104-106.
30. Hall RCW, Zisook S. Paradoxical reactions to benzodiazepines. Brit J Clin Pharmacol. 1981;11:99S-104S.
31. McLelland HA. The forensic implications of benzodiazepine usage. In: Hindmarch I, Beaumont G, Brandon S, Leonard BE, ed. Benzodiazepines: Current Concepts. Biological, Clinical and Social Perspectives. Chichester, UK: John Wiley & Sons Limited; 1990.